Principles and Treatment of Lipoprotein Disorders
Published on 16. December 2011
Book
Paperback/Softback
XXIII, 502 pages
978-3-642-78428-6 (ISBN)
Description
Major advances have been made in the understanding of the molecular mechanisms of atherosclerosis, the disease that still affects more than 50 percent of the population in the highly industrialized countries. This volume covers the most recent advances in the treatment of hyperlipidemia. It represents a necessary update because molecular mechanisms of atherogenesis have been discovered in the past few years and their molecular mechanisms of action identified. Extensively treated are the molecular mechanisms of disease etiology of arteriosclerosis in relation to the major risk factor "hyperlipidemia", rationale for more effective treatment of this disease by dietary means, the treatment of associated or causing diseases, and the treatment using hypolipidemic drugs.
More details
Series
Edition
Softcover reprint of the original 1st ed. 1994
Language
English
Place of publication
Berlin
Germany
Publishing group
Springer Berlin
Target group
Professional and scholarly
Research
Illustrations
XXIII, 502 p.
Dimensions
Height: 235 mm
Width: 155 mm
Thickness: 29 mm
Weight
791 gr
ISBN-13
978-3-642-78428-6 (9783642784286)
DOI
10.1007/978-3-642-78426-2
Schweitzer Classification
Other editions
Additional editions
Gotthard Schettler | Andreas J.R. Habenicht
Principles and Treatment of Lipoprotein Disorders
Book
02/1994
Springer
€85.55
Article exhausted; check different version
Persons
Content
Section A: Physiology and Pathophysiology of Lipid Metabolism.- 1 An Introduction to the Biochemistry and Biology of Blood Lipids and Lipoproteins.- 2 Lipoprotein Metabolism.- 3 Lipoprotein Receptors.- 4 Genetic Disorders of Lipoprotein Metabolism.- 5 Interactions Between Lipoproteins and the Arterial Wall.- 6 Lipoprotein Lipase and Hepatic Lipase.- 7 Animal Models of Lipoprotein Metabolism.- Section B: Lipid Lowering Therapy.- 8 Rationale to Treat.- 9 The Dietary Therapy of Hyperlipidemia: Its Important Role in the Prevention of Coronary Heart Disease.- 10 Lipid Apheresis.- Section C: Lipid Lowering Drugs.- 11 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitors.- 12 Fibrates.- 13 Nicotinic Acid and Derivatives.- 14 Ion Exchange Resins.- 15 Probucol.- 16 Miscellaneous Lipid-Lowering Drugs.